Indolous 75 Capsule ER

Indolous 75 Capsule ER helps in relieving moderate pain and reducing fever. It effectively alleviates pain and inflammation in conditions like rheumatoid arthritis, osteoarthritis, gout, and ankylosing spondylitis.

Indolous 75 Capsule ER should be taken in the dose and duration as advised by your doctor. It should be taken with food or milk to prevent stomach upset. Inform your doctor if you have any history of heart disease or stroke.

Vomiting, stomach pain, nausea, and indigestion are some of the common side effects that might be observed on taking this medicine. It may also cause dizziness, drowsiness, or visual disturbances. Your doctor may regularly monitor your kidney function, liver function, and levels of blood components if you are taking this medicine for long-term treatment. Long-term use may lead to serious complications such as stomach bleeding and kidney problems.

• Pain relief

Pain relief
Indolous 75 Capsule ER belongs to a group of medicines called nonsteroidal anti- inflammatory drugs (NSAIDs). It is used for short-term relief of pain, inflammation, and swelling in conditions that affect joints and muscles. It works by blocking chemical messengers in the brain that tell us we have pain. It can help relieve pain in conditions like rheumatoid arthritis and osteoarthritis.

Take it as it is prescribed to get the most benefit. Do not take more or for longer than needed as that can be dangerous. In general, you should take the lowest dose that works, for the shortest possible time. This will help you to go about your daily activities more easily and have a better, more active, quality of life.

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of DavaIndia

• Visual disturbance
• Vomiting
• Stomach pain/epigastric pain
• Nausea
• Indigestion
• Dizziness
• Drowsiness
• Visual disorder

Take this medicine in the dose and duration as advised by your doctor. Indolous 75 Capsule ER is to be taken with food.

Indolous 75 Capsule ER is a non-steroidal anti-inflammatory drugs (NSAID). It works by blocking the release of certain chemical messengers that cause pain and inflammation (redness and swelling).

• You have been prescribed Indolous 75 Capsule ER to relieve pain and inflammation.

• Take it with food or milk to prevent upset stomach.

• Take it as per the dose and duration prescribed by your doctor. Long term use may lead to serious complications such as stomach bleeding and kidney problems.

• It may cause dizziness, drowsiness or visual disturbances. Use caution while driving or doing anything that requires concentration.

• Avoid consuming alcohol while taking Indolous 75 Capsule ER as it can cause excessive drowsiness and increase your risk of stomach problems.

• Inform your doctor if you have a history of heart disease or stroke.

• Your doctor may regularly monitor your kidney function, liver function and levels of blood components, if you are taking this medicine for long-term treatment.

Furst DE, Ulrich RW, Varkey-Altamirano C. Nonsteroidal Anti-Inflammatory Drugs, Disease Modifying Antirheumatic Drugs, Nonopioids Analgesics, & Drugs Used in Gout. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 627.

Grosser T, Smyth E, FitzGerald GA. Anti-Inflammatory, Antipyretic, and Analgesic Agents; Pharmacotherapy of Gout. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 984-85.

Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 707-712.

Drugs.com. Indomethacin Pregnancy and Breastfeeding Warnings. [Accessed 02 Apr. 2019] (online) Available from:

Chaves RG, Lamounier JA. Breastfeeding and maternal medications. J Pediatr (Rio J). 2004;80(5 Suppl):S189-S198. [Accessed 02 Apr. 2019] (online) Available from:

Central Drugs Standard Control Organisation (CDSCO). [Accessed 02 Apr. 2019] (online) Available from: